M&A Deal Summary

Abcam Acquires MitoSciences

On May 24, 2011, Abcam acquired life science company MitoSciences

Acquisition Highlights
  • This is Abcam’s 1st transaction in the Life Science sector.
  • This is Abcam’s 1st transaction in the United States.
  • This is Abcam’s 1st transaction in Oregon.

M&A Deal Summary
Date 2011-05-24
Target MitoSciences
Sector Life Science
Buyer(s) Abcam
Deal Type Add-on Acquisition

Target

MitoSciences

Eugene, Oregon, United States
MitoSciences produce and distribute immunoassays and high performance monoclonal antibodies via an online catalog consisting of over 400 products in the areas of metabolism and apoptosis.

Search 200,500 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Abcam

Cambridge, United Kingdom
Category Company
Founded 1998
Sector Life Science
Employees1,682
Revenue 362M GBP (2022)
DESCRIPTION

Abcam is a producer and marketer of high quality protein research tools. These tools enable life scientists to analyze components of living cells at the molecular level which is essential in a wide range of fields including drug discovery, diagnostics, and basic research. Abcam was founded in 1998 and is based in Cambridge, the United Kingdom.

DEAL STATS #
Overall 1 of 8
Sector (Life Science) 1 of 8
Type (Add-on Acquisition) 1 of 7
State (Oregon) 1 of 1
Country (United States) 1 of 7
Year (2011) 1 of 2
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2011-09-13 Ascent Scientific

Bristol, United Kingdom

Ascent Scientific was a privately held biochemical company produced and distributed receptor ligands for use by academic researchers. Ligands are substances which bind to proteins, often regulating their function or activity.

Buy -
Mergr

Product

Company

Legal